Wintermute Biomedical Inc

  • Biotech or pharma, therapeutic R&D

Wintermute is a US/Australian company with a proprietary technology that harnesses the therapeutic properties of fatty acids. The company has completed a Phase Ib RCT of its lead product Solexan, a topical treatment for shingles with a novel antiviral mechanism of action.

Address

Melborne
Australia

Website

https://www.wintermutebiomedical.com/

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS